Allergan plc

Allergan plc

Allergan plc

Allergan is a global pharmaceutical company.
Founded
1948
Follow us
Alexa global traffic share
Twitter followers
Acquired by
RetroSense
1
06 Sep 2016
$60,000,000
Teva Pharmaceuticals
1
04 Aug 2016
$40,000,000,000
ANTERIOS
1
07 Jan 2016
the home of AI info

Cerebral Palsy Market 2019 Business Scenario – Allergan Plc, Cell Cure Neuroscience Ltd ...

Fast Company

Botox boom: Allergan stock skyrockets on news of AbbVie acquisition

AVCJ

China's HighLight to exit US-based biotech player Bonti

$2,400,000,000
Xconomy

Allergan to Acquire Fat-Busting Medical Tech Firm Zeltiq for $2.4B

Health Strategy
Xconomy

Allergan, Eying More Neurodegenerative Drugs, Gets Right to Buy LTI

Health Strategy
Acquisition
prnewswire

Allergan Enters Parkinson's Disease Through Option Arrangement with Lysosomal Therapeutics Inc. (LTI) for its Potential...

$125,000,000
Allergan , prnewswire , StreetInsider.com

Allergan Acquires Chase Pharmaceuticals to Expand CNS R&D Pipeline and Build on Commitment to Alzhei

Health
$2,900,000,000
Xconomy

Acelity Sells LifeCell Tissue Repair Unit to Allergan for $2.9B

Strategy Health
$200,000,000
GEN

Allergan to Acquire Motus Therapeutics Genetic Engineering & Biotechnology News - Biotech from Bench to Business

Health Strategy
Xconomy

Allergan Snags Rhythm’s Diabetes-Related GI Drug for $200M

Health
$1,700,000,000
Allergan , The Wall Street Journal

Allergan to Acquire Tobira Therapeutics Expanding Global GI R&D Pipeline and Taking a Leading R&D Po

Health Technology
Xconomy

With Tobira Deal, Allergan Keeps Shopping For "Questionable" Assets

Health Stock markets Strategy
Acquisition
businesswire

Akarna Therapeutics Ltd acquired by Allergan plc | Business Wire

$60,000,000
Xconomy

Allergan Dips Toes into Gene Therapy With $60M Retrosense Buy

Health Science
$40,000,000,000
NoCamels - Israeli Tech and Innovation News

Teva Completes $40B Purchase Of Allergan

Strategy
The Motley Fool

Better Buy: Valeant Pharmaceuticals International, Inc. vs. Allergan

The Motley Fool

Why Is Impax Labs Tumbling 11.7% Today

The Motley Fool

3 Top Stocks to Buy for Your Kids in June

The Motley Fool

Carl Icahn Bets Big on Allergan's CEO

Stock markets Strategy
The Motley Fool

8 Top Stocks Billionaires Love

Stock markets